Lineage Cell Therapeutics (LCTX.TA) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-44.43
-32
-19.56
-7.12

Details

Expected EPS
-8.413466516
Actual EPS
-42.535219999999995
Surprise EPS
-34.12
Surprise Percent
+405.56%

Description

Lineage Cell Therapeutics (LCTX.TA) has reported earnings of -42.535219999999995 per share for Q4 2025.

0 Comments

Share your thoughts